Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
NervGen Pharma Corp
V.NGEN
Alternate Symbol(s):
NGENF
Healthcare
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a...
therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. The Company has two wholly owned subsidiaries, including NervGen US Inc. and NervGen Australia Pty Ltd.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:NGEN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(37)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Apr 25, 2024 8:53pm
PR Firm
This reeks of desperation. Makes zero sense. If results are positive then it will sell itself. Maybe they are gearing up for a stock offering!
(528)
•••
deepoil0808
X
View Profile
View Bullboard History
Post by
deepoil0808
on Apr 25, 2024 8:38pm
Sedar filings HINT at inconclusive evidence (more testing)?
I conducted a review of the insider buying from February 15th 2024 to date. The date of February 15th is when there were leaks of one patient doing well, followed up later with free
...more
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:24pm
@ the Bell: Tech drop takes a bite out of the TSX
Technology shares led the decliners as the sector endured its worst day in more than a month on the TSX, dragged down by crypto miners.
read article.
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:58am
Buzz on the Bullboards: A recap of recent activity and stocks in focus
After a major sell-off, stock markets have been on edge, monitoring corporate earnings to gauge the direction of the economy.
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 17, 2024 9:01am
New Press Release - NervGen Pharma Reports 2023 Year-End Financial Results and Operational Updates
Anticipated completion of enrollment of the chronic cohort in the Phase 1b/2a clinical trial in Q2 2024CA$23 million bought deal financing completed in March 2024 provides expected cash runway through Q3 2025 Fast Track designation granted by U.S. Food and Drug Administration (FDA) for NVG-291 in...
read article.
(528)
•••
deepoil0808
X
View Profile
View Bullboard History
Post by
deepoil0808
on Apr 09, 2024 11:38pm
UGLY chart speaks VOLUMES
I am thinking out loud. If the treatment really worked we would have seen a soaring stock price as results are evident by staff, by doctors, by family members etc.... It would be tough
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 28, 2024 9:02am
New Press Release - NervGen Completes $23 Million Bought Deal Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.Vancouver, British Columbia--(Newsfile Corp. - March 28, 2024) - NervGen Pharma Corp. (TSXV: NGEN) ("NervGen" or the "Company") is pleased to announce the closing of its previously announced public...
read article.
(528)
•••
deepoil0808
X
View Profile
View Bullboard History
Post by
deepoil0808
on Mar 26, 2024 11:44am
Stock sharply down from $ 3.80/share (leaked results???)
Stock has dropped SHARPLY from $ 3.80 per share. Sadly, shareholders are always the last to know. From reading the chart one would speculate that the trial results either are failing or
...more
(0)
•••
holliganz
X
View Profile
View Bullboard History
Comment by
holliganz
on Mar 22, 2024 9:43am
RE:Bought deal RAISES questions. Why now?
the insider your referring to that sold was a director exercising stock options that were expiring. They only had enough cash for this trial. If the trial is successful they have fast track
...more
(528)
•••
deepoil0808
X
View Profile
View Bullboard History
Post by
deepoil0808
on Mar 21, 2024 7:34pm
Bought deal RAISES questions. Why now?
Stock has plunged from +/- $ 3.80 to $ 2.48 today, a big drop. One insider sold +/- 30% of their holdings at $ 3 Market place published an article PROMOTING the company while a bought deal of $ 20
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 21, 2024 4:34pm
New Press Release - Canadian Investment Regulatory Organization Trade Resumption - NGEN
VANCOUVER, BC, March 21, 2024 /CNW/ - Trading resumes in:Company: NervGen Pharma Corp.TSX-Venture Symbol: NGENAll Issues: YesResumption (ET): 8:00 AM03/22/2024CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 21, 2024 4:02pm
New Press Release - NERVGEN ANNOUNCES $20 MILLION BOUGHT DEAL OFFERING
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./VANCOUVER, BC, March 21, 2024 /CNW/ - NervGen Pharma Corp. ("NervGen" or the "Company") (TSXV: NGEN) is pleased to announce that it has entered into an agreement with a syndicate of underwriters...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 21, 2024 3:50pm
New Press Release - Canadian Investment Regulatory Organization Trading Halt - NGEN
VANCOUVER, BC, March 21, 2024 /CNW/ - The following issues have been halted by CIROCompany: NervGen Pharma Corp.TSX-Venture Symbol: NGEN All Issues: YesReason: Pending NewsHalt Time (ET): 3:43 PMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a...
read article.
(1597)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Mar 20, 2024 8:17pm
RE:Article
It's over my head but would this "NerveGen" medicine have any value in combating "Peripheral Neuropathy"?
(0)
•••
snarkymaven
X
View Profile
View Bullboard History
Post by
snarkymaven
on Mar 20, 2024 12:47pm
Article
https://themarketonline.ca/can-nervgen-keep-a-lid-on-explosive-news-2024-03-20/
(0)
•••
snarkymaven
X
View Profile
View Bullboard History
Comment by
snarkymaven
on Mar 20, 2024 12:46pm
RE:Brian Bayley sold 100,000 shares at $ 3/share
There are insiders with large positions of stock at $1 that has a vesting date which is around now. If they do not sell their shares, they lose out. All any insider knows is if they
...more
(0)
•••
snarkymaven
X
View Profile
View Bullboard History
Comment by
snarkymaven
on Mar 20, 2024 12:42pm
RE:RE:RE:RE:Brian Bayley sold 100,000 shares at $ 3/share
There are insiders with large positions of stock at $1 that has a vesting date which is around now. If they do not sell their shares, they lose out. All any insider knows is if they
...more
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study